International Journal on Magnetic Particle Imaging IJMPI
Vol. 11 No. 1 Suppl 1 (2025): Int J Mag Part Imag

Short Abstracts

Evaluating Magnetic Staging Following Sentinel Lymph Node Biopsy: The LowMag Trial

Main Article Content

Sadaf Salamzadeh (R&D Lab manager), Anke Christenhusz (Department of Surgery Medisch Spectrum Twente, Enschede,), Heleen.S van Nie (University of Twente), Anneriet E. Dassen (Department of Surgery Medisch Spectrum Twente, Enschede,), Erik Krooshoop (University of Twente), Bennie ten Haken (University of Twente), Lejla Alic (University of Twente)

Abstract

Background: Accurate identification of metastatic lymph nodes (LNs) is essential for cancer prognosis and treatment planning. In the LowMag clinical trial [1], a magnetic sentinel lymph node biopsy (SLNB) procedure was introduced for patients with invasive breast cancer. Difference between metastatic and non-metastatic LNs was assessed using amount of iron captured in individual LNs and their respective AC susceptibility (ACS).


Methods: Two magnetic devices—the superparamagnetic quantifier (SPaQ) [1,2] and the differential magnetometer handheld (DMH) probe [1,3] —were used to measure iron content and ACS in individual LNs. Additionally, ex vivo LN imaging was performed using a low-field MRI system [1,4], followed by detailed histopathological analysis. A total of 33 LNs from 18 consecutive patients, including four metastatic nodes, were examined.


Results: The low-field MRI findings and histopathological analysis of iron levels were consistent with measurements obtained from SPaQ and DMH probe. A significant difference in iron content was observed between metastatic LNs (DMH: 203.12 ± 87.67 µg; SPaQ: 131.28 ± 53.38 µg) and non-metastatic LNs (DMH: 92.47 ± 89.8 µg; SPaQ: 42.45 ± 46.9 µg). Furthermore, combining two features extracted from the ACS curve—Full Width at Half Maximum (FWHM) and peak values—resulted in a sensitivity of 75.0%, a specificity of 96.6%, and an overall accuracy of 93.9%.


Conclusion: This study suggests that the DiffMag method may offer precise detection of non-metastatic LNs. Additionally, SPaQ in both DiffMag and ACS mode, exhibits higher specificity and greater accuracy than the DMH probe due to its unique design.

Article Details

References

1.C. C. M. O. (CCMO), A complete magnetic radiation free procedure for sentinel lymph node localization. Trial number: 28812.
2. M. Horstman - van de Loosdrecht et al, A novel characterization technique for superparamagnetic iron oxide nanoparticles: The superparamagnetic quantifier, compared with magnetic particle spectroscopy. Review of Scientific Instruments, 2019.
3. S. Waanders, et al, A handheld spio-based sentinel lymph node mapping device using differential magnetometry, Phys Med Bio, 2016.
4. A. Christenhusz, et al, Ex vivo lymph node staging by a portable low-field MRI scanner, In Proceedings of the Joint Annual Meeting ISMRM–ISMRT, Toronto, Canada, 2023.

Most read articles by the same author(s)